Vimarsana
Biggest News Aggregation in the World

First Two Interchangeable News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Two Interchangeable. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Two Interchangeable Today - Breaking & Trending Today

United States - Patent - Regeneron Files Second BPCIA Complaint Against Celltrion's Proposed EYLEA® Biosimilar CT-P42 - Vimarsana News

United States - Patent - Regeneron Files Second BPCIA Complaint Against Celltrion's Proposed EYLEA® Biosimilar CT-P42

On May 17, 2024, Regeneron filed a second infringement litigation against Celltrion's proposed EYLEA® (aflibercept) biosimilar CT-P42, Case No. 1:24-cv-00053 (N.D.W. Va.).

Source: mondaq.com